Wang Xu-Hua, Xu Ding-Qiao, Chen Yan-Yan, Yue Shi-Jun, Fu Rui-Jia, Huang Lu, Tang Yu-Ping
Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, Shaanxi University of Chinese Medicine, Xi'an, China.
Front Pharmacol. 2022 Sep 16;13:952938. doi: 10.3389/fphar.2022.952938. eCollection 2022.
Sepsis is described as a dysregulation of the immune response to infection, which leads to life-threatening organ dysfunction. The interaction between intestinal microbiota and sepsis can't be ignored. Furthermore, the intestinal microbiota may regulate the progress of sepsis and attenuate organ damage. Thus, maintaining or restoring microbiota may be a new way to treat sepsis. Traditional Chinese medicine (TCM) assumes a significant part in the treatment of sepsis through multi-component, multi-pathway, and multi-targeting abilities. Moreover, TCM can prevent the progress of sepsis and improve the prognosis of patients with sepsis by improving the imbalance of intestinal microbiota, improving immunity and reducing the damage to the intestinal barrier. This paper expounds the interaction between intestinal microbiota and sepsis, then reviews the current research on the treatment of sepsis with TCM, to provide a theoretical basis for its clinical application.
Front Endocrinol (Lausanne). 2023
Front Endocrinol (Lausanne). 2022
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024-8
Front Cell Infect Microbiol. 2024
J Ethnopharmacol. 2021-3-1
Front Immunol. 2025-6-27
Front Med (Lausanne). 2025-3-25
Acta Pharm Sin B. 2022-12
Pharmacol Res. 2022-9
Evid Based Complement Alternat Med. 2022-5-21
Front Pharmacol. 2022-1-26